Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06612658Not ApplicableNot Yet Recruiting

Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Expenditure and Reaction Time

Role: collaborator

NCT02281981Not ApplicableWithdrawn

The Effects of Repeated Bouts of Downhill Running and Curcumin Supplementation on Arterial Stiffness During Recovery

Role: collaborator

NCT02139852Withdrawn

Capsaicinoid Ingestion, Human Metabolism and Exercise

Role: collaborator

NCT02138630Not ApplicableWithdrawn

Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)

Role: collaborator

NCT02929849Not ApplicableCompleted

Satiety and Glucose Indices in Adults

Role: collaborator

NCT04874701Phase 4Completed

Effects of Capsimax on Appetite, Energy Intake and Blood Pressure

Role: collaborator

NCT03489226Not ApplicableCompleted

Capsimax Effect on Metabolic Rate, Satiety and Food Intake

Role: collaborator

All 7 trials loaded